X. Lei
6 Papers
4 Citations
X. Lei is an academic researcher. The author has contributed to research in topics: Medicine & Receptor tyrosine kinase. The author has an hindex of 2, co-authored 6 publications.
Chat about Author
Papers
Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma
Yiming Zhang,Rong He,X. Lei,Lianghao Mao,Zhengyu Yin,Xinyu Zhong,Wen Yan Cao,Qiping Zheng,Dapeng Li +8 more
TL;DR: The FRL-score could distinguish immune function, immune score, stromal score, tumor purity, and tumor infiltration of immune cells in different osteosarcoma patients and was associated with immune checkpoint gene expression and half-maximal inhibitory concentration of chemotherapeutic agents.
Journal Article
miR-1297 inhibits osteosarcoma cell proliferation and growth by targeting CCND2.
Pan Jiang,Lianghao Mao,X. Lei,Chunshan Luo,Yiming Zhang,Xinyu Zhong,Zhenyu Yin,Xiaofeng Xu,Dapeng Li,Qiping Zheng +9 more
TL;DR: It is demonstrated that miR-1297 can inhibit proliferation and tumor growth in OS by directly targeting CCND2, which indicates thatMiR- 1297 may represent a novel therapeutic target for osteosarcoma.
5
Inflammation-related research within the field of bladder cancer: a bibliometric analysis
TL;DR: In this article , the authors identified research hotspots and frontiers in the field of inflammatory research in the treatment of bladder cancer. But, there were no relevant bibliometric studies to analyze the inflammation-related research within this field of BC.
4
Prognostic value of receptor tyrosine kinases in malignant melanoma patients: A systematic review and meta-analysis of immunohistochemistry
TL;DR: The findings build concrete evidence that overexpression of RTKs is associated with poor prognosis and clinicopathology in melanoma, highlighting RTK expression has the potential to inform individualized combination therapies and accurate prognostic evaluation.
3
Journal Article
The splicing factor proline and glutamine rich promotes the growth of osteosarcoma via the c-Myc signaling pathway.
Lianghao Mao,Pan Jiang,X. Lei,Bing Zhang,Xinyu Zhong,Zhengyu Yin,Dapeng Li,Yiming Zhang,Qiping Zheng +8 more
TL;DR: In this paper , the role and mechanism of splicing factor proline and glutamine rich (SFPQ) in osteosarcoma was investigated using quantitative real-time PCR, western blot, and fluorescence in situ hybridization (FISH) analyses.